Navigation Links
Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference
Date:11/25/2015

SAN DIEGO, Nov. 25, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the 27th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Wednesday, December 2 at 11:00am ET (8:00am PT).  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.  The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.  Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Neurocrine Biosciences Announces Expansion of its Clinical Pipeline
2. Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results
3. Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Live Audio Webcast Will be on March 10, 2015
4. Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer
5. Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon
6. Neurocrine Biosciences To Present At Deutsche Bank 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference
7. Neurocrine Biosciences Reports Third Quarter 2013 Results
8. Neurocrine Biosciences Reports Second Quarter 2013 Results
9. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results
10. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
11. Representative Scott Peters Visits Avelas Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), ... that two large U.S. studies, published last week, confirm pose a significant health ... Infection Control (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In ...
(Date:11/13/2018)... , ... November 13, 2018 , ... ... of the spine technology market last week that asserts it is still trending ... population. , Humad’s analysis describes market consolidation, pricing pressure and increased ...
(Date:11/13/2018)... Ore. (PRWEB) , ... November 13, 2018 , ... ... at Bio-Logic Aqua® Research Water Life Science® in Grants Pass, Oregon believes in ... Kleyne and Bio-Logic Aqua® Research Water Life Science® sponsors the Power of Water® ...
(Date:11/9/2018)... ... November 08, 2018 , ... uBiome, the leader ... Executive Officer and President of Andes Biotechnologies, to its Scientific Advisory Board. Joining ... brings to uBiome expertise on the genetic studies of hepatitis viruses. The appointment ...
Breaking Biology Technology:
(Date:12/5/2018)... ... December 04, 2018 , ... Slone Partners, North America’s leading ... Michael Mercer at Karius, Inc. as Chief Commercial Officer. Now responsible for developing, ... Karius' headquarters in Redwood City, California and report to CEO Mickey Kertesz Ph.D. ...
(Date:12/5/2018)... SAN DIEGO (PRWEB) , ... December 04, 2018 ... ... to leverage Fastec’s extensive expertise and existing IP in the development of innovative ... technology has been integrated into diverse systems from microfluidics to industrial machinery and ...
(Date:11/27/2018)... , ... November 26, 2018 , ... ... Brandon Wuerth, MD, Founder of the website IBDwatch and Gastroenterology Fellow at the ... scientists and doctors from around the world, Dr. Wuerth will bring to uBiome ...
Breaking Biology News(10 mins):